Pfizer Begins a Phase 12 Study to Evaluate Respiratory Syncytial Virus RSV Vaccine

RSV affects 33 million children globally and leads to approximately 120000 childhood deaths every year1 In the United States approximately 177000 older adults are hospitalized…
Read the full story: Bioportfolio Latest News